or
forgot password

    • cancer clinical trials in san antonio, TX

    • Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue Sarcoma
    CTRC Institute for Drug Development, University of Texas
    San Antonio, Texas 78229-3900
    Metastatic Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma, Unresectable Soft Tissue Sarcoma
    Efficacy and Safety Phase II Dose-ranging Study of SR-T100 to Treat Actinic Keratosis
    Dermatology Clinical Resaerch Center of San Antonio
    San Antonio, Texas 78229
    Actinic Keratosis
    Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects
    START - South Texas Accelerated Research Therapeutics, LLC
    San Antonio, Texas 78229
    Solid Tumors
    Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
    South Texas Accelerated Research Therapeutics, LLC (START)
    San Antonio, Texas 78229
    Advanced Solid Tumors
    Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib
    Investigational Site Number 840023
    San Antonio, Texas 78229
    Hematopoietic Neoplasm
    Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
    Cancer Care Centers of South Texas / HOAST CCC of So. TX- San Antonio(2)
    San Antonio, Texas 78229
    Metastatic Breast Cancer
    A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
    Cancer Care Network of South Texas
    San Antonio, Texas 78229
    Chronic Lymphocytic Leukemia
    A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp
    Dermatology Clinical Research Center of San Antonio
    San Antonio, Texas 78229
    Actinic Keratosis
    Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
    University of Texas Health Science Center at San Antonio

    Trial Locations
    University of Texas Health Science Center at San Antonio
    Cancer Care Centers of South Texas- Northeast
    Breast Cancer
    Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen
    Investigational Site Number 840005
    San Antonio, Texas 78229
    Neoplasm Malignant
    Bevacizumab/Ph 2 for Locally Advanced Head and Neck Cancer
    Cancer Therapy and Research Center at UTHSCSA
    San Antonio, Texas 78229
    Carcinoma, Squamous Cell of Head and Neck
    A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas
    South Texas Accelerated Research Therapeutics
    San Antonio, Texas 78229
    Advanced Solid Tumor, Lymphoma
    Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia
    Methodist Children's Hospital of South Texas
    San Antonio, Texas 78229-3993
    B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Diffuse Large Cell Lymphoma, L3 Childhood Acute Lymphoblastic Leukemia, Stage III Childhood Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma, Untreated Childhood Acute Lymphoblastic Leukemia
    Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
    Sonterra Clinical Research

    Trial Locations
    Sonterra Clinical Research
    Radiant Research
    Obesity, Overweight
    A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
    South Texas Oncology and Hematology, PA South Texas Oncology (2)

    Trial Locations
    South Texas Oncology and Hematology, PA South Texas Oncology (2)
    Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(5)
    Breast Cancer
    Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer
    Cancer Therapy and Research Center University of Texas Health Science Center San Antonio
    San Antonio, Texas 78229
    Prostate Cancer
    M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer
    University of Texas Health Sciences Center
    San Antonio, Texas
    Metastatic Pancreatic Cancer
    A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
    South Texas Accelerated Research Therapeutics
    San Antonio, Texas 78229
    Unspecified Adult Solid Tumor, Protocol Specific
    Pharmacokinetic and Safety Study of Pixantrone in Patients With Metastatic Cancer and Hepatic Impairment
    UTHSCSA-Cancer Therapy-Research Center
    San Antonio, Texas 78229
    Metastatic Cancer
    Postoperative Radiotherapy and Panitumumab in High-Risk Salivary Gland Malignancies
    Cancer Therapy and Research Center at UTHSCSA
    San Antonio, Texas 78229
    Salivary Gland Malignancy
    Oral Hydroxychloroquine Plus Oral Sorafenib to Treat Patients With Refractory or Relapsed Solid Tumors
    Cancer Therapy and Research Center at UTHSCSA
    San Antonio, Texas 78229
    Refractory or Relapsed Solid Tumors
    A Phase 2a Study of Modified Vaccinia Virus to Treat Sorafenib-naïve Advanced Liver Cancer
    University of Texas Health Science Center at San Antonio
    San Antonio, Texas 78284-7811
    Hepatocellular Carinoma
    BT062 in Combination With Lenalidomide/Dexamethasone in Patients With Multiple Myeloma
    University of Texas Health Science Center
    San Antonio, Texas 78284
    Multiple Myeloma
    A Study of Oral CFG920 in Patients With Castration Resistant Prostate Cancer
    Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(2)
    San Antonio, Texas 78229
    Prostatic Neoplasms
    A Phase 1b/2 Study of OMP-59R5 in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer
    South Texas Accelerated Research Thereapeutics, LLC (START)
    San Antonio, Texas 78229
    Stage IV Pancreatic Cancer
    Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
    US Oncology - Cancer Care Center of South Texas, Site #170
    San Antonio, Texas 78229
    Chronic Myeloid Leukemia
    Study of BMS-936558 vs. Everolimus in Pre-Treated Advanced Or Metastatic Clear-cell RCC
    Cancer Therapy and Research Center
    San Antonio, Texas 78229
    Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma
    Phase 2 Reduction of Dietary Mycotoxin Exposure by ACCS100"
    University of Texas Health Science Center Cancer Treatment Research Center
    San Antonio, Texas 78229
    Dietary Carcinogenesis
    Intravesical Administration of INSTILADRIN (rAd-IFN With Syn3) in Patients With Bladder Cancer
    The University Of Texas Health Science Center
    San Antonio, Texas 78229
    Superficial Bladder Cancer
    A Study of MK-8109 (Vintafolide) Given With Chemotherapy in Participants With Advanced Cancers (MK-8109-001)
    Call for Information (Investigational Site 0001)
    San Antonio, Texas 78229
    Advanced Cancer
    Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot be Removed by Surgery
    Southwest Oncology Group
    San Antonio, Texas 78245
    Childhood Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer, Type 1 Papillary Renal Cell Carcinoma, Type 2 Papillary Renal Cell Carcinoma
    Effect of Tivantinib on the QTC Interval in Cancer Subjects
    START - South Texas Accelerated Research Therapeutics, LLC
    San Antonio, Texas 78229
    Solid Tumors
    Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors.
    Cancer Therapy & Research Center / UT Health Science Center SC
    San Antonio, Texas 78229
    Advanced Solid Tumors, Excluding Breast Cancer
    Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of Orally Administered CUDC-101 in Cancer Patients
    Southern Texas Accelerated Research Therapeutics
    San Antonio, Texas 78229
    Cancer
    Study to Assess the Activity of Nexrutine® in Prostate Cancer Patients
    The University of Texas Health Science Center at San Antonio, study site: ALM VA Hospital
    San Antonio, Texas 78229
    Prostate Cancer
    To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)
    Investigational Site Number 840103

    Trial Locations
    Investigational Site Number 840103
    Investigational Site Number 840119
    Rheumatoid Arthritis
    Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors
    Investigational Site Number 840006
    San Antonio, Texas 78229
    Malignant Solid Tumor - Malignant Nervous System Neoplasm
    Phase 1 Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Solid Tumors
    Cancer Therapy and Research Center (CTRC), The University of Texas Health Science Center at San Antonio
    San Antonio, Texas 78229
    Malignant Solid Tumors
    Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients
    Cancer Therapy & Research Center
    San Antonio, Texas 78229
    Advanced Solid Tumor
    Study of G-202 as Second-Line Therapy Following Sorafenib in Hepatocellular Carcinoma
    The University of Texas Health Science Center at San Antonio
    San Antonio, Texas 78229
    Advanced Adult Hepatocellular Carcinoma
    A Dose Escalation Study of OMP-52M51 in Subjects With Solid Tumors
    South Texas Accelerated Research Therapeutics, Llc
    San Antonio, Texas 78229
    Relapsed or Refractory Solid Tumors
    A Twelve Week Safety and Efficacy Study in Rosacea
    Progressive Clinical Research, PA
    San Antonio, Texas 78229
    Papulopustular Rosacea
    A Phase 2 of GS-9973 in Subjects With Relapsed or Refractory Hematologic Malignancies
    Cancer Care Network of South Texas
    San Antonio, Texas 78229
    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma, Indolent Non-Hodgkin's Lymphoma
    Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia
    Southwest Oncology Group
    San Antonio, Texas 78245
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Frailty Study of Older Adults Getting Chemotherapy and Radiation Therapy
    Cancer Therapy and Research Center at UTHSCSA
    San Antonio, Texas 78229
    Cancer
    S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
    Southwest Oncology Group
    San Antonio, Texas 78245
    Prostate Cancer
    Neoadjuvant Rapamycin in Patients Undergoing Radical Cystectomy
    UT Health Science Center San Antonio
    San Antonio, Texas 78229
    Invasive Bladder Cancer Stage II
    Effect of SAR302503 on ECG Activity in Patients With Solid Tumors
    Investigational Site Number 840006

    Trial Locations
    Investigational Site Number 840006
    Investigational Site Number 840008
    Neoplasm Malignant